146 related articles for article (PubMed ID: 19824465)
1. Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.
Bodnar L; Wcislo G; Górnas M; Gasowska-Bodnar A; Wiśniewski P; Stec R; Baranowski W; Szczylik C
Ginekol Pol; 2009 Aug; 80(8):632-6. PubMed ID: 19824465
[TBL] [Abstract][Full Text] [Related]
2. Enormous cystic tumor of peritoneal psammocarcinoma exhibiting complete response to Cisplatin and cyclophosphamide after suboptimal cytoreduction: case report and review of the literature.
Takahashi R; Ueda Y; Shioji M; Adachi S; Ohashi H; Morii E; Aozasa K; Yoshino K; Fujita M; Enomoto T; Kimura T; Tokuhira A
Gynecol Obstet Invest; 2012; 74(2):165-70. PubMed ID: 22584287
[TBL] [Abstract][Full Text] [Related]
3. Primary peritoneal serous psammocarcinoma with recurrent disease and metastasis: a case report and review of the literature.
Akbulut M; Kelten C; Bir F; Soysal ME; Duzcan SE
Gynecol Oncol; 2007 Apr; 105(1):248-51. PubMed ID: 17222893
[TBL] [Abstract][Full Text] [Related]
4. Primary peritoneal serous psammocarcinoma: a case report.
Togănel RD; Şimon I; Zolog A; Simescu R; Cozma A; Muntean V
J Gastrointestin Liver Dis; 2015 Jun; 24(2):253-6. PubMed ID: 26114188
[TBL] [Abstract][Full Text] [Related]
5. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors.
Weir MM; Bell DA; Young RH
Am J Surg Pathol; 1998 Jul; 22(7):849-62. PubMed ID: 9669347
[TBL] [Abstract][Full Text] [Related]
6. Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
Gao B; Lindemann K; Anderson L; Fereday S; Hung J; Alsop K; Tothill RW; Gebski V; Kennedy C; Balleine RL; ; Harnett PR; Bowtell DD; DeFazio A
Gynecol Oncol; 2016 Sep; 142(3):458-64. PubMed ID: 27444035
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
8. Psammocarcinoma with an aggressive course.
Poggi SH; Bristow RE; Nieberg RK; Berek JS
Obstet Gynecol; 1998 Oct; 92(4 Pt 2):659-61. PubMed ID: 9764653
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
[TBL] [Abstract][Full Text] [Related]
11. [CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction].
Gasowska-Bodnar A; Bodnar L; Wcisło GB; Jerzak MM; Szczylik C; Baranowski W
Ginekol Pol; 2008 Feb; 79(2):108-14. PubMed ID: 18510089
[TBL] [Abstract][Full Text] [Related]
12. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics.
Iavazzo C; Vorgias G; Katsoulis M; Kalinoglou N; Dertimas V; Akrivos T
Arch Gynecol Obstet; 2008 Jul; 278(1):53-6. PubMed ID: 18488238
[TBL] [Abstract][Full Text] [Related]
13. Aggressive ovarian psammocarcinoma: a case report.
Zakkouri FA; Berrada N; Kettani F; Mrabti H; Jalil A; Errihani H
Eur J Gynaecol Oncol; 2011; 32(2):214-5. PubMed ID: 21614920
[TBL] [Abstract][Full Text] [Related]
14. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
15. Primary psammocarcinoma of the peritoneum.
Bilgin T; Ozuysal S; Cankiliç H
Int J Gynecol Cancer; 2006; 16 Suppl 1():129-31. PubMed ID: 16515580
[TBL] [Abstract][Full Text] [Related]
16. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
17. Primary peritoneal psammocarcinoma: A case presenting with an upper abdominal mass and elevated CA-125.
Whitcomb BP; Kost ER; Hines JF; Zahn CM; Hall KL
Gynecol Oncol; 1999 May; 73(2):331-4. PubMed ID: 10329057
[TBL] [Abstract][Full Text] [Related]
18. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?
Despierre E; Moerman P; Vergote I; Amant F
Int J Gynecol Cancer; 2006; 16 Suppl 1():273-7. PubMed ID: 16515603
[TBL] [Abstract][Full Text] [Related]
20. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
